Ads
related to: keytruda- What Is KEYTRUDA?
Learn About What KEYTRUDA Is & How
It May Help Eligible Patients.
- Side Effects
Learn About Possible Side Effects
at the Official Patient Site.
- Treatment Options
Learn About Treatment
Options With KEYTRUDA.
- Get Financial Help
Find Assistance and Payment
Information for Eligible Patients.
- Clinical Trial Results
See Clinical Trial Results
at the Official Site.
- Taking KEYTRUDA?
Learn What to Expect When
Taking KEYTRUDA.
- What Is KEYTRUDA?
Search results
Merck’s KEYTRUDA shows survival benefits in Phase III TNBC trial
Clinical Trials Arena via Yahoo Finance· 17 hours agoMerck has reported that its Phase III KEYNOTE-522 clinical trial of KEYTRUDA to treat high-risk,...
FDA sets review date for Merck's KEYTRUDA in mesothelioma treatment By Investing.com
Investing.com· 8 hours agoMerck & Co., Inc., a global healthcare leader, has announced that the U.S. Food and Drug...
Merck's Multi-Billion Cancer Drug Keytruda Aces Late-Stage Breast Cancer Study (UPDATED)
Benzinga via Yahoo Finance· 1 day agoTuesday, Merck & Co Inc (NYSE:MRK) released topline data from hase 3 KEYNOTE-522 trial of Keytruda...
Merck to buy eye-focused drug developer EyeBio for as much as $3 billion
Reuters via Yahoo Finance· 15 hours ago(Reuters) -Merck on Wednesday agreed to buy privately held biotech EyeBio for as much as $3 billion,...
Merck eyes purchase of ophthalmology company
WFMZ Eastern Pennsylvania and Western New Jersey· 4 hours agoTake Merck, for example. Its blockbuster cancer drug, Keytruda, is now the largest selling drug in the world. In the past few weeks, studies have shown ...
Merck is spending $3 billion on an eye drug developer as it braces to lose a key cancer patent
Quartz· 11 hours agoPharma giant Merck said on Wednesday that it is acquiring the privately-held eye drug developer...
ASCO 2024: Rakuten’s photoimmunotherapy and Keytruda combo shows efficacy in HNSCC
Clinical Trials Arena via Yahoo Finance· 2 days agoUS-based Rakuten Medical has announced positive interim data from the Phase Ib/II trial of its...
Merck Reportedly Nearing $1.3B Acquisition Of EyeBio To Expand Eye-Care Market Presence - Merck & Co...
Benzinga· 17 hours agoMerck & Co., Inc. MRK is reportedly on the verge of acquiring EyeBio, an eye drug company, for a sum...
Merck Reaches $1.3 Billion Deal for Eye-Drug Company EyeBio
The Wall Street Journal· 15 hours agoIn recent years, Chief Executive Rob Davis has been doing deals to lessen Merck’s reliance on the...
Merck Nears $1.3 Billion Cash Deal for Eye-Drug Company EyeBio, WSJ Reports
US News & World Report· 1 day agoMerck did not immediately respond to Reuters' request for a comment, while Eyebiotech declined to comment. Eyebiotech is a clinical stage opthalmology company, with operations in the U.S. and ...
Ads
related to: keytruda
